Bausch Health Companies Inc. decided on an initial public offering of shares to divest its Bausch + Lomb Inc. vision health business, but not until after an IPO for its Solta Medical aesthetic skin and body technology division.
The Canadian firm says it plans to separate Solta first, with an IPO in December or January, and at least...







